Literature DB >> 3978244

Patients with early breast cancer benefit from effective axillary treatment.

J R Harris, R T Osteen.   

Abstract

We have reviewed the available clinical data on the benefit of axillary treatment in patients with early breast cancer. The results of these studies suggest that perhaps 5-10% of patients are cured by effective axillary treatment. We conclude that effective axillary treatment should still be considered an essential aspect of primary treatment.

Entities:  

Mesh：

Year:  1985        PMID： 3978244     DOI： 10.1007/bf01807645

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


  14 in total

1.  CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY.

Authors:  C D Haagensen; A P Stout
Journal:  Ann Surg       Date:  1943-11       Impact factor: 12.969

2.  Significance of occult metastases. A study of breast cancer.

Authors:  J W PICKREN
Journal:  Cancer       Date:  1961 Nov-Dec       Impact factor: 6.860

3.  I. The Results of Radical Operations for the Cure of Carcinoma of the Breast.

Authors:  W S Halsted
Journal:  Ann Surg       Date:  1907-07       Impact factor: 12.969

4.  Significance of axillary macrometastases and micrometastases in mammary cancer.

Authors:  A G Huvos; R V Hutter; J W Berg
Journal:  Ann Surg       Date:  1971-01       Impact factor: 12.969

5.  Cancer research campaign (King's/Cambridge) trial for early breast cancer. A detailed update at the tenth year. Cancer Research Campaign Working Party.

Authors: 
Journal:  Lancet       Date:  1980-07-12       Impact factor: 79.321

6.  The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.

Authors:  B Fisher; N Wolmark; M Bauer; C Redmond; M Gebhardt
Journal:  Surg Gynecol Obstet       Date:  1981-06

7.  Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.

Authors:  B Fisher; N Slack; D Katrych; N Wolmark
Journal:  Surg Gynecol Obstet       Date:  1975-04

8.  Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size.

Authors:  P P Rosen; P E Saigo; D W Braun; E Weathers; A A Fracchia; D W Kinne
Journal:  Ann Surg       Date:  1981-11       Impact factor: 12.969

9.  The surgeon's role in primary breast cancer.

Authors:  J Hayward
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

10.  Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients.

Authors:  P Valagussa; G Bonadonna; U Veronesi
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860
View more
  13 in total

1.  Controversies in the Surgical Management of Operable Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

2.  Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer.

Authors:  G Cserni
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 3.  Diagnosis of axillary lymph node metastases in patients with breast cancer.

Authors:  M Noguchi; N Katev; I Miyazaki
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Patients with early breast cancer may be harmed from 'effective' axillary treatment.

Authors:  A N Papaioannou
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Predicting axillary lymph node metastases in breast carcinoma patients.

Authors:  P L Choong; C J deSilva; H J Dawkins; G F Sterrett; P Robbins; J M Harvey; J Papadimitriou; Y Attikiouzel
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  How do I deal with the axilla in patients with a positive sentinel lymph node?

Authors:  Conrad B Falkson
Journal:  Curr Treat Options Oncol       Date:  2011-12

7.  The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.

Authors:  W H Choi; I R Yoo; J H O; S H Kim; S K Chung
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

8.  Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.

Authors:  Igor Langer; Walter Richard Marti; Ulrich Guller; Holger Moch; Felix Harder; Daniel Oertli; Markus Zuber
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

9.  Which patients need an axillary clearance after sentinel node biopsy?

Authors:  Anastasia Pazaiti; Ian S Fentiman
Journal:  Int J Breast Cancer       Date:  2011-08-24

10.  99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection.

Authors:  L Biassoni; M Granowska; M J Carroll; S J Mather; R Howell; D Ellison; F A MacNeill; C A Wells; R Carpenter; K E Britton
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.